The Role of Renal Prostaglandins in the Regulation of Renal Sodium Excretion

Author(s):  
Herbert J. Kramer ◽  
Jochen Kipnowski ◽  
Rainer Düsing
2019 ◽  
Vol 8 (8) ◽  
Author(s):  
Shaoxiong Wang ◽  
Xiaorong Tan ◽  
Peng Chen ◽  
Shuo Zheng ◽  
Hongmei Ren ◽  
...  

2001 ◽  
Vol 442 (4) ◽  
pp. 505-510 ◽  
Author(s):  
Cecilia Odlind ◽  
Ilkka Reenilä ◽  
Pekka Männistö ◽  
Jonas Ekblom ◽  
Peter Hansell

1982 ◽  
Vol 21 (1) ◽  
pp. 70-77 ◽  
Author(s):  
Elias A. Lianos ◽  
Nahid Alavi ◽  
Morris Tobin ◽  
Rocco Venuto ◽  
Carl J. Bentzel

Hypertension ◽  
2014 ◽  
Vol 64 (suppl_1) ◽  
Author(s):  
Weili Wang ◽  
Wei-Qing Han ◽  
Qing Zhu ◽  
Imad Damaj ◽  
Pin-Lan Li ◽  
...  

Although there are extensive studies on the regulation of renal sodium excretion by adrenergic pathway, the role of cholinergic pathway in the renal sodium excretion is largely unknown. The present study characterized the expression of α7 nicotinic acetylcholine receptor (nAChR) in the kidneys and determined the functional role of this nAChR subtype in urinary sodium excretion in Sprague Dawley rats. RT-PCR and Western blot analyses showed that α7 nAChR was present in the kidneys. Immunohistochemistry analysis demonstrated that the strongest immunostaining of α7 nAChR was observed in the distal tubules and collecting ducts in the kidneys. Infusion of an α7 nAChR agonist PNU-282987 (2.7 μM, 10 μl/min) into the renal medulla dramatically increased the urine volume (from 15.4 ± 2.1 to 42.5 ± 3.9 μl/min/g kwt) and sodium excretion (from 1.26 ± 0.18 to 4.15 ± 0.60 μmole/min/g kwt), which was blocked by an α7 nAChR antagonist methyllycaconitine (MLA, 5 μM, 10 μl/min), in anesthetized rats. Infusion of PNU-282987 did not cause any change in renal medullary blood flow as measured by Laser Doppler flowmeter. In addition, intra-renal medullary infusion of MLA (5 μM, 10 μl/min) significantly inhibited the volume expansion-induced increase of urine volume and sodium excretion by 25%. These data suggest that activation of renal medullary α7 nAChR produces a natriuretic effect through its tubular action in rats. (Supported by NIH grant HL89563 and HL106042)


2016 ◽  
Vol 28 (4) ◽  
Author(s):  
A. V. Kutina ◽  
D. V. Golosova ◽  
A. S. Marina ◽  
E. I. Shakhmatova ◽  
Y. V. Natochin

Hypertension ◽  
1992 ◽  
Vol 19 (1_Suppl) ◽  
pp. I78-I78 ◽  
Author(s):  
A. K. Gupta ◽  
R. V. Clark ◽  
K. A. Kirchner

1999 ◽  
Vol 276 (3) ◽  
pp. R790-R798 ◽  
Author(s):  
Ai-Ping Zou ◽  
Kasem Nithipatikom ◽  
Pin-Lan Li ◽  
Allen W. Cowley

This study determined the levels of adenosine in the renal medullary interstitium using microdialysis and fluorescence HPLC techniques and examined the role of endogenous adenosine in the control of medullary blood flow and sodium excretion by infusing the specific adenosine receptor antagonists or agonists into the renal medulla of anesthetized Sprague-Dawley rats. Renal cortical and medullary blood flows were measured using laser-Doppler flowmetry. Analysis of microdialyzed samples showed that the adenosine concentration in the renal medullary interstitial dialysate averaged 212 ± 5.2 nM, which was significantly higher than 55.6 ± 5.3 nM in the renal cortex ( n = 9). Renal medullary interstitial infusion of a selective A1antagonist, 8-cyclopentyl-1,3-dipropylxanthine (DPCPX; 300 pmol ⋅ kg−1 ⋅ min−1, n = 8), did not alter renal blood flows, but increased urine flow by 37% and sodium excretion by 42%. In contrast, renal medullary infusion of the selective A2 receptor blocker 3,7-dimethyl-1-propargylxanthine (DMPX; 150 pmol ⋅ kg−1 ⋅ min−1, n = 9) decreased outer medullary blood flow (OMBF) by 28%, inner medullary blood flows (IMBF) by 21%, and sodium excretion by 35%. Renal medullary interstitial infusion of adenosine produced a dose-dependent increase in OMBF, IMBF, urine flow, and sodium excretion at doses from 3 to 300 pmol ⋅ kg−1 ⋅ min−1( n = 7). These effects of adenosine were markedly attenuated by the pretreatment of DMPX, but unaltered by DPCPX. Infusion of a selective A3receptor agonist, N 6-benzyl-5′-( N-ethylcarbonxamido)adenosine (300 pmol ⋅ kg−1 ⋅ min−1, n = 6) into the renal medulla had no effect on medullary blood flows or renal function. Glomerular filtration rate and arterial pressure were not changed by medullary infusion of any drugs. Our results indicate that endogenous medullary adenosine at physiological concentrations serves to dilate medullary vessels via A2 receptors, resulting in a natriuretic response that overrides the tubular A1 receptor-mediated antinatriuretic effects.


1982 ◽  
Vol 170 (4) ◽  
pp. 517-522
Author(s):  
Y. R. Barbella ◽  
J. N. D. Wurpel ◽  
W. B. Severs

Sign in / Sign up

Export Citation Format

Share Document